Related Experiment Video
Updated: Jul 17, 2026
10:52
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
A computational model for the Huntington disease.
Yashar Sarbaz1, Masood Banae, Shahriar Gharibzadeh
1Faculty of Electrical Engineering, Sahand University of Technology, Tabriz, Iran.
Medical Hypotheses
|January 30, 2007
Summary
This study models Huntington's disease (HD) using computational methods, simulating abnormal glutamate release in the basal ganglia. The model accurately replicates HD's characteristic jerky movements and suggests potential therapeutic targets.
Area of Science:
- Neuroscience
- Computational Biology
- Systems Biology
Background:
- Huntington's disease (HD) involves basal ganglia degeneration, with abnormal glutamate release implicated in movement disorders.
- The complex pathophysiology of HD necessitates advanced analytical tools like computational modeling.
- Existing simulations for HD are limited, highlighting the need for a more comprehensive approach.
Purpose of the Study:
- To develop a computational model of the basal ganglia that simulates Huntington's disease pathophysiology.
- To analyze the impact of abnormal glutamate signaling on motor function using a mathematical framework.
- To identify potential therapeutic interventions by evaluating model parameter changes.
Main Methods:
- A computational model was designed based on physiological findings of basal ganglia function.
- Glutamate abnormality was modeled as environmental noise using random number generators.
- Neurotransmitter effects (excitatory/inhibitory) were represented using Hill functions, and internal block behavior used closed-loop systems.
- Noise levels, dependent on parameter 'g', differentiated healthy (g=1) and diseased (g=10) states.
Main Results:
- The model successfully simulated the abrupt, chorea-like movements characteristic of Huntington's disease.
- Reducing the noise parameter 'g' from 10 to 3 decreased movement severity, while g<3 ceased jerky movements.
- Model outputs exhibited stochastic properties (movement timing, size, shape), mirroring real-world HD conditions.
- Simulated increases in substance P and GABA levels ameliorated disease symptoms within the model.
Conclusions:
- The developed computational model provides a valuable tool for understanding Huntington's disease mechanisms.
- The model's ability to replicate key disease features and respond to parameter changes supports its physiological relevance.
- Findings suggest that modulating neurotransmitter levels, potentially through drugs like gabapentin, could alleviate HD symptoms, warranting clinical investigation.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...